MedTrace Logo

Post-market Clinical Follow-up of Pfmmedical Ports

NCT05209828 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2024-04-05

No results posted yet for this study

Summary

Prospective, monocentric, non-randomised, observational post-market clinical follow-up study in Germany to obtain post-market information on the pfmmedical ports with a follow-up (FU) of 6 months. The focus is on patient reported satisfaction, clinical application, and complication rates.

Conditions

  • Vascular Access Port
  • Patient Satisfaction

Interventions

DEVICE

pfmmedical implantable vascular access ports

Implantion of an implantable vascular access port which facilitates repeated vascular access intended for the delivery of medications, intravenous fluids, parenteral nutrition solutions or blood products and blood sampling using a Huber needle.

Sponsors & Collaborators

  • pfm medical gmbh

    lead INDUSTRY

Principal Investigators

  • Phillip Knebel, Prof. Dr. · University Hospital Heidelberg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-13
Primary Completion
2023-03-09
Completion
2023-03-09
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05209828 on ClinicalTrials.gov